Hematology Special Issue (February) 2021 | CURE

Adding to the Regimen: NCCN Updates in Leukemia and Lymphoma

February 15, 2021

Research News and Updates

The NCCN has updated its recommendations for chronic lymphocytic leukemia and small lymphocytic lymphoma to now include Brukinsa as a first- and second-line therapy in a subgroup of patients.